These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 17894021

  • 21. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection.
    Obel N, Høier-Madsen M, Kangro H.
    APMIS; 1996 Jun; 104(6):424-8. PubMed ID: 8774671
    [Abstract] [Full Text] [Related]

  • 22. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
    Aygun D, Kuskucu MA, Sahin S, Adrovic A, Barut K, Yıldız M, Sharifova S, Midilli K, Cokugras H, Camcıoglu Y, Kasapcopur O.
    Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
    [Abstract] [Full Text] [Related]

  • 23. Elevated Antibody Titers to Epstein-Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus.
    Knudsen J, Trier NH, Draborg AH, Nielsen CT, Jacobsen S, Højrup P, Houen G.
    Viruses; 2023 Apr 17; 15(4):. PubMed ID: 37112967
    [Abstract] [Full Text] [Related]

  • 24. Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants.
    Holder B, Miles DJ, Kaye S, Crozier S, Mohammed NI, Duah NO, Roberts E, Ojuola O, Palmero MS, Touray ES, Waight P, Cotten M, Rowland-Jones S, van der Sande M, Whittle H.
    PLoS One; 2010 Nov 17; 5(11):e14013. PubMed ID: 21103338
    [Abstract] [Full Text] [Related]

  • 25. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ.
    JAMA; 2001 Dec 26; 286(24):3083-8. PubMed ID: 11754673
    [Abstract] [Full Text] [Related]

  • 26. An ELISA method to compute endpoint titers to Epstein-Barr virus and cytomegalovirus: application to population-based studies.
    Stowe RP, Ruiz RJ, Fagundes CP, Stowe RH, Chen M, Glaser R.
    J Immunol Methods; 2014 Jun 26; 408():64-9. PubMed ID: 24859346
    [Abstract] [Full Text] [Related]

  • 27. Acute viral hepatitis presenting as cytomegalovirus, hepatitis E and Epstein-Barr virus IgM antibody positive.
    Huang Q, Li XH, Zhu C, Yan J, Song Z, Zhang S, Hu Y, Chen L, Ling Y.
    Antivir Ther; 2016 Jun 26; 21(2):171-3. PubMed ID: 26376744
    [Abstract] [Full Text] [Related]

  • 28. Association of clinical and serological parameters of systemic lupus erythematosus patients with Epstein-Barr virus antibody profile.
    Chougule D, Nadkar M, Rajadhyaksha A, Pandit-Shende P, Surve P, Dawkar N, Khadilkar P, Patwardhan M, Kaveri S, Ghosh K, Pradhan V.
    J Med Virol; 2018 Mar 26; 90(3):559-563. PubMed ID: 28734074
    [Abstract] [Full Text] [Related]

  • 29. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W.
    Infection; 2003 Oct 26; 31(5):318-23. PubMed ID: 14556056
    [Abstract] [Full Text] [Related]

  • 30. The role of cytomegalovirus, Haemophilus influenzae and Epstein Barr virus in Guillain Barre syndrome.
    Nafissi S, Vahabi Z, Sadeghi Ghahar M, Amirzargar AA, Naderi S.
    Acta Med Iran; 2013 Jul 13; 51(6):372-6. PubMed ID: 23852841
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.
    J Immunol Methods; 2014 Jun 13; 408():101-13. PubMed ID: 24877879
    [Abstract] [Full Text] [Related]

  • 32. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P, Beynon S, Whybin R, Brennan C, Vollmer-Conna U, Hickie I, Lloyd A.
    J Med Virol; 2003 Aug 13; 70(4):617-23. PubMed ID: 12794726
    [Abstract] [Full Text] [Related]

  • 33. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.
    Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H.
    Br J Cancer; 2010 May 25; 102(11):1665-9. PubMed ID: 20407437
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
    Deeba E, Koptides D, Gaglia E, Constantinou A, Lambrianides A, Pantzaris M, Krashias G, Christodoulou C.
    Mol Immunol; 2019 Jan 25; 105():270-275. PubMed ID: 30562647
    [Abstract] [Full Text] [Related]

  • 35. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ, Lin KH, Lin SC, Tsai WC, Yen JH, Chang SJ, Lu SN, Liu HW.
    J Rheumatol; 2005 Jan 25; 32(1):44-7. PubMed ID: 15630723
    [Abstract] [Full Text] [Related]

  • 36. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Agmon-Levin N, Dagan A, Peri Y, Anaya JM, Selmi C, Tincani A, Bizzaro N, Stojanovich L, Damoiseaux J, Cohen Tervaert JW, Mosca M, Cervera R, Shoenfeld Y.
    Clin Exp Rheumatol; 2017 Jan 25; 35(6):929-935. PubMed ID: 28770708
    [Abstract] [Full Text] [Related]

  • 37. Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.
    Palafox Sánchez CA, Satoh M, Chan EK, Carcamo WC, Muñoz Valle JF, Orozco Barocio G, Oregon Romero E, Navarro Hernández RE, Salazar Páramo M, Cabral Castañeda A, Vázquez Del Mercado M.
    Arthritis Res Ther; 2009 Jan 25; 11(1):R27. PubMed ID: 19232124
    [Abstract] [Full Text] [Related]

  • 38. Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles.
    Fechtner S, Berens H, Bemis E, Johnson RL, Guthridge CJ, Carlson NE, Demoruelle MK, Harley JB, Edison JD, Norris JA, Robinson WH, Deane KD, James JA, Holers VM.
    Arthritis Rheumatol; 2022 Apr 25; 74(4):597-603. PubMed ID: 34605217
    [Abstract] [Full Text] [Related]

  • 39. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C, Agawa H, Sairenji T, Inoue Y.
    Arch Virol; 2006 May 25; 151(5):895-903. PubMed ID: 16362642
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of a multiplexed bead assay for assessment of Epstein-Barr virus immunologic status.
    Klutts JS, Liao RS, Dunne WM, Gronowski AM.
    J Clin Microbiol; 2004 Nov 25; 42(11):4996-5000. PubMed ID: 15528686
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.